levosalbutamol [Ligand Id: 9816] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL1002 (Albuterol (r)-form, ASF-1096, Levalbuterol, Levosalbutamol, R-salbutamol, Xopenex)
  • β2-adrenoceptor/Beta-2 adrenergic receptor in Human [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
There should be some charts here, you may need to enable JavaScript!
  • β1-adrenoceptor in Human [GtoPdb: 28] [UniProtKB: P08588]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
β2-adrenoceptor/Beta-2 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells B 5.25 pKi 5623.41 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells B 5.25 pKi 5623 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells in presence of 100 uM phenylboronic acid B 5.33 pKi 4677.35 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells in presence of 100 uM phenylboronic acid B 5.33 pKi 4677 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells in presence of 100 uM boric acid B 5.42 pKi 3802 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells in presence of 100 uM boric acid B 5.42 pKi 3801.89 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting in presence of 100 uM phenylboronic acid F 6.34 pEC50 457.09 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting in presence of 100 uM phenylboronic acid F 6.34 pEC50 457 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting in presence of 100 uM boric acid F 6.56 pEC50 275.42 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting in presence of 100 uM boric acid F 6.56 pEC50 275 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting F 6.84 pEC50 145 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting F 6.84 pEC50 144.54 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
β1-adrenoceptor in Human [GtoPdb: 28] [UniProtKB: P08588]
GtoPdb - - 4.7 pKi - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]
GtoPdb - - 6.2 pEC50 - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]